Wednesday, Sep 23, 2026 · SEC filings
What the smart money revealed on Sep 23
247 insider filings came in. We hid 65 planned (10b5-1) sellers and 126 people whose filings were routine, like grants and tax withholding.
Electra Therapeutics (ETRA) Director Carl Gordon bought $20M
1.33M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.
Cascade Real Assets Fund (CRAFX) President Stephen Nesbitt bought $5M
500,000 shares on the open market. Not a grant or an option exercise.
Kayne Anderson BDC (KBDC) Director James Robo bought $1.5M
114,961 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Diameter Dynamic Credit Fund Co-President Jonathan Lewinsohn bought $1M
98,814 shares on the open market. Not a grant or an option exercise.
Medpace (MEDP) President & CEO August Troendle sold $44.4M
Not marked as a planned 10b5-1 sale. Sold 14% of the shares they held directly. Still holds 433,372 shares.
KE (BEKE) Executive Director Yigang Shan sold $18.1M
Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 53.87M shares.
Aura Minerals (AUGO) Director Mauad Sousa sold $15M
Not marked as a planned 10b5-1 sale. Sold 99% of the shares they held directly. Still holds 1,041 shares.
13F season
Holdings as of Jun 30, 2026 are due Aug 14
8,899 funds have filed so far. 8,900 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Sep 23.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.